| abstract |
The present invention relates to a medicament of formula (I) useful for the treatment and / or prophylaxis of a mammal, and a medicament useful for the treatment of diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders, and NF-κB-induced kinases lt; / RTI > inducing kinase (also known as NIK, MAP3K14). The present invention also relates to pharmaceutical compositions comprising said compounds and to the use of said compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, obesity and metabolic disorders including diabetes, and autoimmune disorders . (I) |